-+ 0.00%
-+ 0.00%
-+ 0.00%

NKGen Biotech CEO presents troculeucel neurodegenerative disease data at Biologics Manufacturing Korea 2026

PUBT·09/10/2026 12:08:11
Listen to the news
NKGen Biotech CEO presents troculeucel neurodegenerative disease data at Biologics Manufacturing Korea 2026
  • NKGen Biotech will present on troculeucel at Biologics Manufacturing Korea 2026 in Incheon, South Korea, Sept. 17-18, 2026.
  • Talk scheduled for Sept. 18, 2026, 11:00-11:25 a.m. KST; focus on potential use in neurodegenerative diseases.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nkgen Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609100805PRIMZONEFULLFEED9821283) on September 10, 2026, and is solely responsible for the information contained therein.